Discriminative stimulus effects of nalbuphine in nontreated and morphine-treated pigeons

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 2, 1999, Pages 445-448

  Walker, Ellen A ^a   Hawkins, Eric R ^a   Tiano, Michael J ^a   Picker, Mitchell J ^a   Dykstra, Linda A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Efficacy; Morphine; Nalbuphine; Naltrexone; Pigeons; Three choice discrimination; Withdrawal

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR AGONIST; NALBUPHINE; NALTREXONE; SODIUM CHLORIDE;

ABSTINENCE; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG POTENCY; EMBRYO; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PIGEON; PRIORITY JOURNAL; TRAINING;

ANALGESICS, OPIOID; ANIMALS; COLUMBIDAE; CUES; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; MORPHINE; NALBUPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; REVERSAL LEARNING;

COLUMBA;

EID: 0032843327     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00086-6     Document Type: Conference Paper

References (12)

1. France C.P., Woods J.H. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. J. Pharmacol. Exp. Ther. 254:1990;626-632.
2. Gerak L.R., France C.P. Discriminative stimulus effects of nalbuphine in rhesus monkeys. J. Pharmacol. Exp. Ther. 276:1996;523-531.
3. Holtzman S.G. Discriminative stimulus effects of morphine withdrawal in the dependent rat. Suppression by opiate and nonopiate drugs J. Pharmacol. Exp. Ther. 233:1985;80-86.
4. Jasinski D.R., Mansky P.A. Evaluation of nalbuphine for abuse potential. Clin. Pharmacol. Ther. 13:1972;78-90.
5. Picker M.J., Benyas S., Horwitz J.A., Thompson K., Mathewson Smith M.A. Discriminative stimulus effects of butorphanol. Influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists J. Pharmacol. Exp. Ther. 279:1996;1130-1141.
6. Preston K.L., Bigelow G.E., Liebson I.A. Antagonist effects of nalbuphine in opioid-dependent human volunteers. J. Pharmacol. Exp. Ther. 248:1989;929-937.
7. Vanecek S.A., Young A.M. Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behav. Pharmacol. 6:1995;669-681.
8. Walker E.A., Makhay M.M., House J.D., Young A.M. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. J. Pharmacol. Exp. Ther. 271:1994;959-968.
9. Walker E.A., Richardson T.M., Young A.M. In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine. Psychopharmacology (Berlin). 125:1996;113-119.
10. Walker E.A., Young A.M. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. J. Pharmacol. Exp. Ther. 267:1993;322-330.
11. White J.M., Holtzman S.G. Three-choice discrimination in the rat. Morphine, cyclazocine, and saline J. Pharmacol. Exp. Ther. 217:1981;254-262.
12. Young A.M., Masaki M.A., Geula C. Discriminative stimulus effects of morphine. Effects of training dose on agonist and antagonist effects of mu opioids J. Pharmacol. Exp. Ther. 261:1992;246-257.